Review/Decisions/Processing/Policy

Manuscripts that are judged to be of insufficient quality or unlikely to be competitive enough for publication will be returned to the authors at the initial stage. The remaining manuscripts go through a single-blind review process, and possible decisions are: accept as is, minor revision, major revision, or reject. See sample of evaluation form. Authors should submit back their revisions within 14 days in the case of minor revision, or 30 days in the case of major revision. To submit a revision please go submission page, fill out the form, mark "Revised", attach the revision (MSword) and submit when completed. Manuscripts with significant results are typically reviewed and published at the highest priority.

Plagiarism: There is a zero-tolerance policy towards plagiarism (including self-plagiarism) in our journals. Manuscripts are screened for plagiarism by ​Docol©c a plagiarism finding tool, before or during publication, and if found they will be rejected at any stage of processing. See sample of Docol©c-Report.

Date of issue
All accepted articles are published Quarterly (around 25th of March, June, September and December, each year) in full text on the internet.

Publication Charges
No peer-reviewing charges are required. However, there is a $85 editor fee for the processing of each primary accepted paper. Payment can be made by credit card, bank transfer, money order or check. Instruction for payment is sent during publication process as soon as manuscript is accepted. Meanwhile, this journal encourage the academic institutions in low-income countries to publish high quality scientific results, free of charges.

The Waiver policy
The submission fee will be waived for invited authors, authors of hot papers, and corresponding authors who are editorial board members of the Asian Journal of Medical and Pharmaceutical Researches. The Journal will consider requests to waive the fee for cases of financial hardship (for high quality manuscripts and upon acceptance for publication). Requests for waiver of the submission fee must be submitted via individual cover letter by the corresponding author and cosigned by an appropriate institutional official to verify that no institutional or grant funds are available for the payment of the fee. Letters including the manuscript title and manuscript ID number should be sent to: editor [at] ajmpr.science-line.com. It is expected that waiver requests will be processed and authors will be notified within two business day.

The OA policy
Asian Journal of Medical and Pharmaceutical Researches is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of Open Access.

Authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to the following guidelines.

## The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).

## The submission file is in Microsoft Word, RTF, or PDF document file format.

## Where available, URLs for the references have been provided.

## The text is single-spaced; uses a 10-point font; and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.

## The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

(Revised on 27 January 2019)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.